Oneview Healthcare PLC (ASX: ONE) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Oneview Healthcare PLC Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Oneview Healthcare PLC (ASX: ONE)
Latest News
Share Market News
Here's why the Oneview (ASX:ONE) share price is climbing today
Share Gainers
Up another 6%, Oneview (ASX:ONE) share price hits 10-bagger status today
Healthcare Shares
Why the Oneview (ASX:ONE) share price is climbing today
⏸️ ASX Shares
These 5 ASX shares are delivering the biggest gains in 2021
Healthcare Shares
Oneview (ASX:ONE) share price jumps 15% today. Here's why
Healthcare Shares
Why the Oneview (ASX:ONE) share price is rocketing 29% today
Share Market News
Here's why the Oneview (ASX:ONE) share price is rocketing 14%
Share Market News
Afterpay and Zip were among the most traded ASX shares last week
Share Market News
The Oneview Healthcare (ASX:ONE) share price rockets 650% this year
Share Market News
Here's why the Oneview (ASX:ONE) share price has exploded 106% higher
Share Market News
ASX stock of the day: Why Oneview Healthcare (ASX:ONE) shares are rocketing 140% today
Share Gainers
These small cap ASX shares are on the rise on Friday
ONE ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Oneview Healthcare PLC
Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It provides various solutions such as Inpatient Solution, Outpatient Solution, Clinical Pathways, and others. The company generates its revenue in the form of software usage and content revenue, support income, and license fees. Geographically the company operates in Ireland, the United States, Australia, and the Middle East, and Asia. Generating, a majority of its revenue is from Australia. The group has one reportable segment which provides a patient engagement solution for the healthcare sector.
ONE Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
28 Mar 2024 | $0.33 | $0.01 | 3.20% | 188,688 | $0.33 | $0.34 | $0.32 |
27 Mar 2024 | $0.31 | $-0.02 | -6.06% | 153,630 | $0.33 | $0.33 | $0.30 |
26 Mar 2024 | $0.33 | $0.02 | 6.50% | 261,274 | $0.32 | $0.34 | $0.31 |
25 Mar 2024 | $0.31 | $0.00 | 0.00% | 443,151 | $0.30 | $0.31 | $0.28 |
22 Mar 2024 | $0.31 | $0.00 | 0.00% | 174,062 | $0.30 | $0.31 | $0.30 |
21 Mar 2024 | $0.31 | $0.02 | 6.90% | 626,160 | $0.29 | $0.31 | $0.24 |
20 Mar 2024 | $0.29 | $-0.02 | -6.45% | 587,835 | $0.31 | $0.31 | $0.29 |
19 Mar 2024 | $0.31 | $-0.04 | -11.59% | 598,330 | $0.34 | $0.34 | $0.30 |
18 Mar 2024 | $0.35 | $-0.02 | -5.56% | 147,061 | $0.37 | $0.37 | $0.34 |
15 Mar 2024 | $0.36 | $-0.01 | -2.74% | 614,909 | $0.37 | $0.37 | $0.34 |
14 Mar 2024 | $0.37 | $-0.01 | -2.70% | 689,917 | $0.37 | $0.37 | $0.35 |
13 Mar 2024 | $0.37 | $-0.02 | -5.13% | 1,027,796 | $0.40 | $0.40 | $0.35 |
12 Mar 2024 | $0.39 | $0.01 | 2.63% | 715,625 | $0.37 | $0.39 | $0.37 |
11 Mar 2024 | $0.38 | $0.02 | 5.56% | 709,957 | $0.37 | $0.38 | $0.37 |
08 Mar 2024 | $0.36 | $-0.03 | -7.79% | 1,600,732 | $0.39 | $0.41 | $0.36 |
07 Mar 2024 | $0.39 | $0.04 | 11.59% | 1,182,654 | $0.36 | $0.39 | $0.35 |
06 Mar 2024 | $0.35 | $0.00 | 0.00% | 438,864 | $0.34 | $0.36 | $0.34 |
05 Mar 2024 | $0.35 | $-0.01 | -2.82% | 593,995 | $0.36 | $0.36 | $0.34 |
04 Mar 2024 | $0.36 | $0.01 | 2.90% | 829,555 | $0.35 | $0.38 | $0.34 |
01 Mar 2024 | $0.35 | $0.00 | 0.00% | 226,186 | $0.34 | $0.35 | $0.33 |
29 Feb 2024 | $0.34 | $0.00 | 0.00% | 504,382 | $0.34 | $0.35 | $0.33 |
28 Feb 2024 | $0.34 | $0.02 | 6.15% | 1,033,183 | $0.33 | $0.35 | $0.33 |
27 Feb 2024 | $0.33 | $0.01 | 3.13% | 655,646 | $0.31 | $0.33 | $0.29 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
12 Mar 2024 | Mark Cullen | Sell | 250,000 | $97,500 |
As advised by the company. Sale of shares held buy Trust executed by
Trustee, CDI |
27 Nov 2023 | Nashina Asaria | Sell | 175,000 | $36,320 |
As advised by the company. Sale of CDIs over ordinary shares to sell
mandatory Irish payroll income taxes on recent vesting of RSUs |
27 Nov 2023 | Joseph Rooney | Sell | 283,928 | $58,346 |
On-market trade. Sale of CDIs over ordinary shares to sell
mandatory Irish payroll income taxes on recent vesting of RSUs |
20 Nov 2023 | Joseph Rooney | Issued | 535,714 | $107,143 |
Conversion of securities. Value, CDIS
|
20 Nov 2023 | Joseph Rooney | Exercise | 535,714 | $107,142 |
Conversion of securities. 470,833 Restricted Share Units , value
|
20 Nov 2023 | James Fitter | Issued | 664,286 | $132,857 |
Conversion of securities. Value
|
20 Nov 2023 | James Fitter | Exercise | 664,286 | $132,857 |
Conversion of securities. Value, 18,000,000 Restricted Share Units
|
20 Nov 2023 | Nashina Asaria | Exercise | 357,143 | $71,429 |
Conversion of securities. 874,999 Restricted Share Units,Value
|
20 Nov 2023 | Nashina Asaria | Issued | 357,143 | $71,429 |
Conversion of securities. Value, cdi
|
27 Oct 2023 | Nashina Asaria | Issued | 208,333 | $49,999 |
Issue of securities. 12,32,142 Restricted Share Units
|
27 Oct 2023 | Barbara Nelson | Issued | 1,077,898 | $258,695 |
Issue of securities. 1,077,898 Restricted Share Units
|
27 Oct 2023 | Joseph Rooney | Issued | 470,833 | $112,999 |
Issue of securities. 1,006,547 Restricted Share Units
|
27 Oct 2023 | Mark Cullen | Issued | 1,182,065 | $283,695 |
Issue of securities. 1,182,065 Restricted Share Units
|
30 Aug 2023 | James Fitter | Issued | 9,000,000 | $1,935,000 |
Issue of securities. 18,664,286 Restricted Share Units
|
30 Aug 2023 | James Fitter | Buy | 83,333 | $17,916 |
Participation in share purchase plan. 14,268,804 CDIs
|
30 Aug 2023 | James Fitter | Expiry | 1,749,194 | $376,076 |
As advised by the company. Expiry of Restricted Share Units as vesting
conditions not met by deadline, 96,64,286 RSU |
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr James Fitter | Chief Executive OfficerExecutive Director | Jan 2013 |
Mr Filter has been CEO of Oneview Healthcare since January 2013, helping transition what was then a 10 person start-up into a publicly traded Company in just over three years. He has over 25 years of experience in the global financial markets during which time he has lived and worked on four continents. James founded and managed an independent asset management company and spent over ten years as a professional investor and an independent advisor prior to joining Oneview.
|
Mr Joseph Rooney | Non-Executive Director | Feb 2016 |
Mr Rooney joined Oneview in 2016 and assumed the role of Chairman upon the death of James Osborne. Joseph is also Chair of Fundraising for the Clongowes Wood College Foundation. Until the end of 2012, Joseph was a partner and global strategist at Autonomy Capital Research LLP, a global macro hedge fund. Prior to this, he held several senior positions at Lehman Brothers Inc, including MD, Head of Global Strategy and trustee of their UK pension fund. Joseph resigned voluntarily as Chairman on 4 November 2019, but remains on the board as an Independent Director.
|
Mr Mark Cullen | Non-Executive Director | Dec 2015 |
Mr Cullen has 30-year career with Deutsche Bank and DWS Asset Management, most recently as CEO of DWS Americas & COO of DWS Group GmbH & Co. Mark was previously the Global Head of Audit for Deutsche Bank from March 2015 to December 2018. Mark is currently working as a Senior Business Advisor to BlackRock in London and is a non-executive Director of nimbus, a cloud-based platform that transforms employee management and workforce capabilities for on-site, hybrid, and remote staff with compliance-driven workforce management, contact centre and business continuity solutions.
|
Ms Nashina Asaria | Non-Executive Director | May 2021 |
Ms Asaria is currently Chief Product and Marketing Officer (CPMO) for Nanthealth, a digital health company listed on the Nasdaq. Prior to Nanthealth, she was CPMO of UpHealth Inc. a digital health company listed on the New York Stock Exchange. Nashina was Chief Product Officer at Cloudbreak Health LLC, a US telehealth company that was merged into UpHealth Inc. in June 2021. She is passionate about mission driven initiatives with commercial viability. She has a record of sustaining endeavours in international partnerships, business strategies, business development, product management, marketing, and deployment. As a Board Member of Cloudbreak Health, as well as its Chief Product Officer, she was responsible for Product Marketing, Product Management and Requirements, UI design, Software Engineering, Implementation and Customer Experience.
|
Ms Barbara Nelson | Non-Executive Director | Oct 2023 |
Ms Nelson is a public board director and C-level technology leader, who currently serves on three corporate boards, one which recently launched a successful IPO. She has been CEO twice. She brings over 15 years of P&L and general management experience in SaaS/cloud services, IaaS, cybersecurity, software, mobile, video, data management, storage, IT infrastructure and semiconductors. This diversity of expertise enables pressure tested strategic clarity particularly in tackling complex challenges to deliver growth while managing risk. Barbara serves as an independent director for Backblaze (Nasdaq: BLZE), a leading independent provider of SaaS/IaaS storage and data management. She serves on the board of GSI Technology (Nasdaq: GSIT), an AI semiconductor and SaaS company. Barbara is also an independent director for o8t, a private company that has developed an AI platform for brain mapping, offering tools used in neurosurgery today, and solutions that could address mental illness in the future
|
Ms Helena D'Arcy | Acting Chief Financial Officer and Company Secretary | Jul 2020 |
-
|
Helena D'Arcy | Acting Chief Financial Officer and Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
HSBC Custody Nominees (Australia) Limited | 163,120,477 | 30.50% |
Citicorp Nominees Pty Limited | 53,393,682 | 10.00% |
Bell Potter Nominees Ltd <Bb Nominees A/C> | 37,817,801 | 7.10% |
HSBC Custody Nominees (Australia) Limited GSCO ECA | 17,501,640 | 3.30% |
HSBC Custody Nominees (Australia) Limited A/C 2 | 15,335,556 | 2.90% |
James Fitter | 14,185,471 | 2.70% |
BNP Paribas Noms Pty Ltd <DRP> | 13,487,937 | 2.50% |
Manderrah Pty Limited | 12,000,000 | 2.20% |
Mark McCloskey | 9,455,467 | 1.80% |
HSBC Custody Nominees (Australia) Limited i | 9,061,700 | 1.70% |
S3 Consortium Holdings Pty Ltd <Nextinvestors Dot Com A/C> | 6,840,000 | 1.30% |
HSBC Custody Nominees (Australia) Limited ii | 6,700,000 | 1.30% |
UBS Nominees Pty Ltd | 5,315,407 | 1.00% |
Top 4 Pty Ltd <The Foundation Inv S/F A/C> | 4,800,000 | 0.90% |
OV No.1 Pty Ltd <The Ov A/C> | 4,210,798 | 0.80% |
Walling Pty Ltd <CJ Howard Super Fund A/C> | 4,155,965 | 0.80% |
Kensington Trust Singapore Limited <IS&P First Names Sing A/C> | 2,606,045 | 0.50% |
Michael Kaminski | 2,444,143 | 0.50% |
Mr Kamal Yogendra Joshi and Mrs Deepa Joshi | 2,356,444 | 0.40% |
Alexander James Hill | 2,250,000 | 0.40% |